{'fraction_non_alphanumeric': 0.027932960893854747, 'fraction_numerical': 0.00558659217877095, 'mean_word_length': 6.0, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A Review on Severe Acute Respiratory Infection (SARI) and its Clinical Management in Suspect/Confirmed Novel Coronavirus (nCoV) Cases

SARI is the most of viral infections that cause generalised clinical symptoms that cannot be easily differentiated from other respiratory infections. Monitoring SARI cases of influenza strains such as H1N1 and Sars-Cov-2, which triggers Covid-19, helps create trends of infection nationally and enhances disease monitoring, which informs response and preparedness to containment. In present article information about genome, Clinical management of severe acute respiratory illness (SARI) in suspect/confirmed novel coronavirus (nCoV) cases by immediate implementation of appropriate IPC measures, early supportive therapy and monitoring, management of hypoxemic respiratory failure, management of septic shock and specific anti-Novel-CoV treatments were given.